BACK
 
Filing Date Form TypeDescription   
   
2019-08-088-KCurrent report, items 2.02 and 9.01 Acc-no: 0001213900-19-014955 (34 Act)  Size: 116 KB
2019-06-078-KCurrent report, item 5.07 Acc-no: 0001213900-19-010341 (34 Act)  Size: 23 KB
2019-06-048-KCurrent report, items 1.01, 3.03, and 9.01 Acc-no: 0001615774-19-009097 (34 Act)  Size: 47 KB
2019-05-098-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-19-007378 (34 Act)  Size: 98 KB
2019-02-148-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-19-002524 (34 Act)  Size: 123 KB
2018-11-018-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-18-011870 (34 Act)  Size: 169 KB
2018-09-218-KCurrent report, items 8.01 and 9.01 Acc-no: 0001615774-18-009793 (34 Act)  Size: 40 KB
2018-09-178-KCurrent report, items 1.01 and 9.01 Acc-no: 0001615774-18-009597 (34 Act)  Size: 214 KB
2018-08-028-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-18-007460 (34 Act)  Size: 127 KB
2018-06-118-KCurrent report, item 5.07 Acc-no: 0001615774-18-005040 (34 Act)  Size: 17 KB
2018-05-038-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-18-003269 (34 Act)  Size: 98 KB
2018-02-018-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-18-000772 (34 Act)  Size: 130 KB
2017-11-028-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-17-006154 (34 Act)  Size: 162 KB

SRTS Chart by TradingView

Sensus Healthcare Reports Second Quarter 2019 Financial Results
8/8/2019 8:05:00 PM

BOCA RATON, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions, announces financial results for the three and six months ended June 30, 2019.

Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019
7/30/2019 6:57:00 PM

BOCA RATON, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 8, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter ended June 30, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

Sensus Healthcare to Present at the Raymond James Inaugural Life Sciences and MedTech Conference
6/10/2019 3:00:00 PM

BOCA RATON, Fla., June 10, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Raymond James Inaugural Life Sciences and MedTech Conference on Wednesday, June 19 at 2:25 p.m. Eastern time.  The conference will be held June 18-19, 2019 at the Lotte New York Palace Hotel in New York City.

Sensus Healthcare to Present at Upcoming Investor Conferences
9/5/2017 2:50:00 PM

Management unable to present at Liolios Gateway conference due to Hurricane Irma 
Management unable to present at Liolios Gateway conference due to Hurricane Irma
Sensus Healthcare to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
8/23/2017 8:01:00 PM

BOCA RATON, Fla., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), has been invited to present at the 2017 Gateway Conference, which is being held on September 6-7, 2017 at the Four Seasons Hotel San Francisco.

Sensus to Present at the 2017 Marcum MicroCap Conference
6/5/2017 2:18:00 PM

BOCA RATON, Fla., June 05, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe Sardano, the Company’s Chief Executive Officer, will present a corporate overview to investors at the 2017 Marcum MicroCap Conference on Thursday, June 15th at 11:00 a.m. Eastern time. The conference will be held at the Grand Hyatt Hotel in New York City on June 15th and 16th.